Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing

Abstract Type VI CRISPR enzymes have been developed as programmable RNA-guided Cas proteins for eukaryotic RNA editing. Notably, Cas13 has been utilized for site-targeted single base edits, demethylation, RNA cleavage or knockdown and alternative splicing. However, the ability to edit large stretche...

Full description

Bibliographic Details
Main Authors: David N. Fiflis, Nicolas A. Rey, Harshitha Venugopal-Lavanya, Beatrice Sewell, Aaron Mitchell-Dick, Katie N. Clements, Sydney Milo, Abigail R. Benkert, Alan Rosales, Sophia Fergione, Aravind Asokan
Format: Article
Language:English
Published: Nature Portfolio 2024-03-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-46172-4
_version_ 1797259208423374848
author David N. Fiflis
Nicolas A. Rey
Harshitha Venugopal-Lavanya
Beatrice Sewell
Aaron Mitchell-Dick
Katie N. Clements
Sydney Milo
Abigail R. Benkert
Alan Rosales
Sophia Fergione
Aravind Asokan
author_facet David N. Fiflis
Nicolas A. Rey
Harshitha Venugopal-Lavanya
Beatrice Sewell
Aaron Mitchell-Dick
Katie N. Clements
Sydney Milo
Abigail R. Benkert
Alan Rosales
Sophia Fergione
Aravind Asokan
author_sort David N. Fiflis
collection DOAJ
description Abstract Type VI CRISPR enzymes have been developed as programmable RNA-guided Cas proteins for eukaryotic RNA editing. Notably, Cas13 has been utilized for site-targeted single base edits, demethylation, RNA cleavage or knockdown and alternative splicing. However, the ability to edit large stretches of mRNA transcripts remains a significant challenge. Here, we demonstrate that CRISPR-Cas13 systems can be repurposed to assist trans-splicing of exogenous RNA fragments into an endogenous pre-mRNA transcript, a method termed CRISPR Assisted mRNA Fragment Trans-splicing (CRAFT). Using split reporter-based assays, we evaluate orthogonal Cas13 systems, optimize guide RNA length and screen for optimal trans-splicing site(s) across a range of intronic targets. We achieve markedly improved editing of large 5’ and 3’ segments in different endogenous mRNAs across various mammalian cell types compared to other spliceosome-mediated trans-splicing methods. CRAFT can serve as a versatile platform for attachment of protein tags, studying the impact of multiple mutations/single nucleotide polymorphisms, modification of untranslated regions (UTRs) or replacing large segments of mRNA transcripts.
first_indexed 2024-04-24T23:05:46Z
format Article
id doaj.art-4a9e799fbf1b4f619012e055594df9cf
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-24T23:05:46Z
publishDate 2024-03-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-4a9e799fbf1b4f619012e055594df9cf2024-03-17T12:30:12ZengNature PortfolioNature Communications2041-17232024-03-0115111410.1038/s41467-024-46172-4Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicingDavid N. Fiflis0Nicolas A. Rey1Harshitha Venugopal-Lavanya2Beatrice Sewell3Aaron Mitchell-Dick4Katie N. Clements5Sydney Milo6Abigail R. Benkert7Alan Rosales8Sophia Fergione9Aravind Asokan10Department of Biomedical Engineering, Duke UniversityDepartment of Surgery, Duke University School of MedicineDepartment of Biomedical Engineering, Duke UniversityDepartment of Surgery, Duke University School of MedicineDepartment of Surgery, Duke University School of MedicineDepartment of Surgery, Duke University School of MedicineDepartment of Biomedical Engineering, Duke UniversityDepartment of Surgery, Duke University School of MedicineDepartment of Biomedical Engineering, Duke UniversityDepartment of Surgery, Duke University School of MedicineDepartment of Biomedical Engineering, Duke UniversityAbstract Type VI CRISPR enzymes have been developed as programmable RNA-guided Cas proteins for eukaryotic RNA editing. Notably, Cas13 has been utilized for site-targeted single base edits, demethylation, RNA cleavage or knockdown and alternative splicing. However, the ability to edit large stretches of mRNA transcripts remains a significant challenge. Here, we demonstrate that CRISPR-Cas13 systems can be repurposed to assist trans-splicing of exogenous RNA fragments into an endogenous pre-mRNA transcript, a method termed CRISPR Assisted mRNA Fragment Trans-splicing (CRAFT). Using split reporter-based assays, we evaluate orthogonal Cas13 systems, optimize guide RNA length and screen for optimal trans-splicing site(s) across a range of intronic targets. We achieve markedly improved editing of large 5’ and 3’ segments in different endogenous mRNAs across various mammalian cell types compared to other spliceosome-mediated trans-splicing methods. CRAFT can serve as a versatile platform for attachment of protein tags, studying the impact of multiple mutations/single nucleotide polymorphisms, modification of untranslated regions (UTRs) or replacing large segments of mRNA transcripts.https://doi.org/10.1038/s41467-024-46172-4
spellingShingle David N. Fiflis
Nicolas A. Rey
Harshitha Venugopal-Lavanya
Beatrice Sewell
Aaron Mitchell-Dick
Katie N. Clements
Sydney Milo
Abigail R. Benkert
Alan Rosales
Sophia Fergione
Aravind Asokan
Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing
Nature Communications
title Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing
title_full Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing
title_fullStr Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing
title_full_unstemmed Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing
title_short Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing
title_sort repurposing crispr cas13 systems for robust mrna trans splicing
url https://doi.org/10.1038/s41467-024-46172-4
work_keys_str_mv AT davidnfiflis repurposingcrisprcas13systemsforrobustmrnatranssplicing
AT nicolasarey repurposingcrisprcas13systemsforrobustmrnatranssplicing
AT harshithavenugopallavanya repurposingcrisprcas13systemsforrobustmrnatranssplicing
AT beatricesewell repurposingcrisprcas13systemsforrobustmrnatranssplicing
AT aaronmitchelldick repurposingcrisprcas13systemsforrobustmrnatranssplicing
AT katienclements repurposingcrisprcas13systemsforrobustmrnatranssplicing
AT sydneymilo repurposingcrisprcas13systemsforrobustmrnatranssplicing
AT abigailrbenkert repurposingcrisprcas13systemsforrobustmrnatranssplicing
AT alanrosales repurposingcrisprcas13systemsforrobustmrnatranssplicing
AT sophiafergione repurposingcrisprcas13systemsforrobustmrnatranssplicing
AT aravindasokan repurposingcrisprcas13systemsforrobustmrnatranssplicing